<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01834157</url>
  </required_header>
  <id_info>
    <org_study_id>HEALTH-F5-2012-305495-OT2</org_study_id>
    <nct_id>NCT01834157</nct_id>
  </id_info>
  <brief_title>Improvement of Hand Dysfunction by Arthritis in Systemic Sclerosis</brief_title>
  <official_title>The &quot;DeSScipher&quot; Project - to Decipher the Best Treatment for Systemic Sclerosis - Observational Trial 2: Improvement of Hand Dysfunction by Arthritis in Systemic Sclerosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Prof. Laszlo Czirjak</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>European Union</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Giessen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Paris 5 - Rene Descartes</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Florence</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Campania &quot;Luigi Vanvitelli&quot;</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Basel</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University College, London</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Charite University, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Leeds</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Schoen Klinik Hamburg Eilbek</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Pecs</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Systemic sclerosis (SSc) is an orphan, multiorgan disease affecting the connective tissue of
      the skin and several internal organs. Beside skin involvement, digital ulcers, tendinitis,
      calcinosis and flexion contractures, the presence of hand arthritis is a major contributor to
      impairment of hand function in systemic sclerosis. Several immunomodulatory drugs used in
      other rheumatic diseases (including methotrexate, leflunomide, azathioprine, mycophenolate
      mofetil and low-dose corticosteroids) can potentially improve arthritis and consequently hand
      function in systemic sclerosis. For the assessment of arthritis, the CDAI (clinical disease
      activity index) is validated in rheumatoid arthritis, and may be useful for SSc-related
      arthritis, too.

      This observational trial is part of the collaborative project &quot;DeSScipher&quot;, one out of five
      observational trials to decipher the optimal management of systemic sclerosis. Aim of this
      observational trial is to:

        -  investigate the efficacy and safety of different treatments on hand dysfunction in
           systemic sclerosis patients with hand arthritis and

        -  to validate the CDAI for arthritis in systemic sclerosis.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>April 2013</start_date>
  <completion_date type="Anticipated">November 2017</completion_date>
  <primary_completion_date type="Anticipated">November 2017</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>12 Months</target_duration>
  <primary_outcome>
    <measure>Improvement of HAQ-DI (CHAQ-DI in jSSc) by at least -0.21 in one year</measure>
    <time_frame>12 months</time_frame>
    <description>Improvement from baseline in Health Assessment Questionnaire - Disability Index (Child Health Assessment Questionnaire - Disability Index in juvenile systemic sclerosis) by at least -0,21(moderate improvement) in one year</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Improvement of the CHFS in one year</measure>
    <time_frame>12 months</time_frame>
    <description>Improvement of the Cochin Hand Function Scale in one year</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Improvement of the CDAI in one year</measure>
    <time_frame>12 months</time_frame>
    <description>Improvement of the Clinical Disease Activity Index in one year</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Improvement of the SDAI in one year</measure>
    <time_frame>12 months</time_frame>
    <description>Improvement of the Simplified Disease Activity Index in one year</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Improvement of the DAS28(We) in one year</measure>
    <time_frame>12 months</time_frame>
    <description>Improvement of the Disease Activity Score 28 (using 4 variables, including erythrocyte sedimentation rate) in one year</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Improvement of the DAS28(CRP) in one year</measure>
    <time_frame>12 months</time_frame>
    <description>Improvement of the Disease Activity Score 28 (using 4 variables, including C-reactive protein) in one year</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Validation of the CDAI in systemic sclerosis</measure>
    <time_frame>12 months</time_frame>
    <description>Exploratory endpoint: Validation of the Clinical Disease Activity Index in systemic sclerosis</description>
  </other_outcome>
  <other_outcome>
    <measure>Validation of the SDAI in systemic sclerosis</measure>
    <time_frame>12 months</time_frame>
    <description>Exploratory endpoint: Validation of the Simplified Disease Activity Index in systemic sclerosis</description>
  </other_outcome>
  <other_outcome>
    <measure>Validation of the DAS28(ESR) in systemic sclerosis</measure>
    <time_frame>12 months</time_frame>
    <description>Exploratory endpoint: Validation of the Disease Activity Score 28 (using 4 variables, including erythrocyte sedimentation rate) in systemic sclerosis</description>
  </other_outcome>
  <other_outcome>
    <measure>Validation of the DAS28(CRP) in systemic sclerosis</measure>
    <time_frame>12 months</time_frame>
    <description>Exploratory endpoint: Validation of the Disease Activity Score 28 (using 4 variables, including C-reactive protein) in systemic sclerosis</description>
  </other_outcome>
  <other_outcome>
    <measure>Evaluation of the incidence and potential predictors of deterioration of hand dysfunction and progression of arthritis in systemic sclerosis</measure>
    <time_frame>24 months</time_frame>
    <description>Evaluation of the incidence and potential predictors of deterioration of hand dysfunction and progression of arthritis in systemic sclerosis</description>
  </other_outcome>
  <other_outcome>
    <measure>Incidence of drug-related adverse events</measure>
    <time_frame>24 months</time_frame>
    <description>Evaluation of the incidence of drug-related adverse events</description>
  </other_outcome>
  <other_outcome>
    <measure>Incidence of withdrawal from treatment due to drug-related adverse events</measure>
    <time_frame>24 months</time_frame>
    <description>Evaluation of the incidence of withdrawal from treatment due to drug-related adverse events</description>
  </other_outcome>
  <number_of_groups>7</number_of_groups>
  <enrollment type="Anticipated">160</enrollment>
  <condition>Systemic Sclerosis</condition>
  <condition>Arthritis</condition>
  <arm_group>
    <arm_group_label>methotrexate</arm_group_label>
    <description>methotrexate with or without low-dose corticosteroids</description>
  </arm_group>
  <arm_group>
    <arm_group_label>other DMARDs</arm_group_label>
    <description>other DMARDs (leflunomide, azathioprine, mycophenolate mofetil) with or without low-dose corticosteroids</description>
  </arm_group>
  <arm_group>
    <arm_group_label>low-dose corticosteroids</arm_group_label>
    <description>low-dose corticosteroids without DMARDs</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No DMARD or corticosteroids</arm_group_label>
    <description>No DMARD or corticosteroid treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CPH/CSA - Exploratory cohort</arm_group_label>
    <description>cyclophosphamide or cyclosporine-A with or without other DMARDs or low-dose corticosteroids</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Biologics - Exploratory cohort</arm_group_label>
    <description>Biologic therapy with or without other DMARDs or low-dose corticosteroids</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Combinations - Exploratory cohort</arm_group_label>
    <description>Combination of two or more DMARDs with or without low-dose corticosteroids</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        The study population is adult and juvenile systemic sclerosis patients from the EUSTAR
        cohort (MEDSonline database) and the jSScWG cohort.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Juvenile and adult Systemic sclerosis patients, with diagnosis according to the
             ACR/EULAR adult SSc criteria and PRES/ACR/EULAR juvenile SSc criteria respectively

          -  Clinical signs of arthritis (defined as ≥2 tender and swollen joints)

        Exclusion Criteria:

          -  Presence of significant, long standing articular pain due to other cause than
             autoimmune disease

          -  Presence of hand disability caused by other, than autoimmune disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ulf Müller-Ladner, Prof.</last_name>
    <role>Study Chair</role>
    <affiliation>Justus-Liebig-University Gießen, Kerckhoff Clinic, Departement of Rheumatology and Clinical Immunology</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Laszlo Czirjak, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>PECSI TUDOMANYEGYETEM - UNIVERSITY OF PECS</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Laszlo Czirjak, Prof.</last_name>
    <email>laszlo.czirjak@aok.pte.hu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Ghent, Department of Rheumatology</name>
      <address>
        <city>Gent</city>
        <zip>9000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Vanessa Smith, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dubrava University Hospital</name>
      <address>
        <city>Zagreb</city>
        <country>Croatia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Jadranka Morovic-Vergles</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Assiut and Sohage University Hospital Rheumatology Department Assiut University Hospital</name>
      <address>
        <city>Assiut</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Manal Hassanien</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Department of Internal Medicine Hôpital Claude Huriez</name>
      <address>
        <city>Lille cedex</city>
        <zip>59035</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Eric Hachulla, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Université Paris Descartes, Hôpital Cochin, Service de Rhumatologie A &amp; INSERM 1016</name>
      <address>
        <city>Paris</city>
        <zip>75014</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Yannick Allanore, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Justus-Liebig-University Gießen, Kerckhoff Clinic, Departement of Rheumatology and Clinical Immunology</name>
      <address>
        <city>Bad Nauheim</city>
        <zip>61231</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Ulf Müller-Ladner, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Charité Universitätsmedizin Berlin, Charité Centrum 12 für Innere Medizin und Dermatologie, Medizinische Klinik mit Schwerpunkt Rheumatologie und Klinische Immunologie</name>
      <address>
        <city>Berlin</city>
        <zip>10117</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Gabriela Riemekasten, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätshautklinik Köln</name>
      <address>
        <city>Cologne</city>
        <zip>50397</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Nicolas Hunzelmann, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Erlangen</name>
      <address>
        <city>Erlangen</city>
        <zip>91054</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Jörg Distler, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Endokrinologikum Frankfurt</name>
      <address>
        <city>Frankfurt</city>
        <zip>60596</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Brigitte Krummel-Lorenz</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre for Pediatric Rheumatology, Klinikum Eilbek</name>
      <address>
        <city>Hamburg</city>
        <zip>22081</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Ivan Foeldvari, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medizinische Universitätsklinik Abt. II</name>
      <address>
        <city>Tübingen</city>
        <zip>72076</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Jörg Henes, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Krankenhaus St. Josef</name>
      <address>
        <city>Wuppertal</city>
        <zip>42105</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Tim Schmeiser, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pecsi Tudomanyegyetem - University of Pecs</name>
      <address>
        <city>Pecs</city>
        <zip>H-7622</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Laszlo Czirjak, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Istituto di Clinica Medica Generale, Ematologia ed Immunologia Clinica, Università Politecnica delle Marche, Polo Didattico, University of Ancona</name>
      <address>
        <city>Ancona</city>
        <zip>60020</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Armando Gabrielli, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Florence, Denothe Centre, Division of Rheumatology AOUC, Department of Biomedicine</name>
      <address>
        <city>Firenze</city>
        <zip>50139</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Marco Matucci-Cerinic, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Department of Rheumatology, University of Cagliari-Policlinico Universitario</name>
      <address>
        <city>Monserrato</city>
        <zip>554</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Alessandra Vacca</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Policlinico, Via Pansini</name>
      <address>
        <city>Napoli-Italia</city>
        <zip>5-80131</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Gabriele Valentini, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Padova</name>
      <address>
        <city>Padova</city>
        <zip>35128</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Franco Cozzi, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Divisione di Reumatologia, Università di Roma La Sapienza, Dipartimento di Clinica e Terapia medica applicata, Policlinico Umberto I</name>
      <address>
        <city>Roma</city>
        <zip>00161</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Guido Valesini, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Department of Internal Medicine and Rheumatology Clinic, Ion Cantacuzino Clinical Hospital</name>
      <address>
        <city>Bucharest</city>
        <zip>020475</zip>
        <country>Romania</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Carina Mihai</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Reumatologie, University of Medicine &amp; Pharmacy,&quot;Iuliu Hatieganu&quot; Cluj</name>
      <address>
        <city>Cluj-Napoca</city>
        <zip>40 0006</zip>
        <country>Romania</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Simona Rednic</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>GR.T.Popa Center for Biomedical Research, European Center for Translational Research, &quot;GR.T.Popa&quot; University of Medicine and Pharmacy, Rehabilitation Hospital</name>
      <address>
        <city>Iasi</city>
        <zip>700661</zip>
        <country>Romania</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Cordina Ancuta</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinic of Nephrology, Internal and Occupational Diseases</name>
      <address>
        <city>Moscow</city>
        <zip>119992</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Sergey Moiseev, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Antonina Sosnovskaya</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institute of Rheumatology, Russian Academy of Medical Science</name>
      <address>
        <city>Moscow</city>
        <zip>119992</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Lidia Ananieva, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institute of Rheumatology Belgrade</name>
      <address>
        <city>Belgrade</city>
        <zip>11000</zip>
        <country>Serbia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Nemanja Damjanov, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Madrid Norte Sanchinarro</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Paloma García de la Peña Lefebvre de la Peña Lefebvre, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Felix-Platter Spital</name>
      <address>
        <city>Basel</city>
        <zip>CH 4012 Basel</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Ulrich Walker, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Zurich, Department of Rheumatology</name>
      <address>
        <city>Zurich</city>
        <zip>8006</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Oliver Distler, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Marmara, Department of Rheumatology</name>
      <address>
        <city>Istanbul</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Sule Kurhan Yavuz, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Universitiy of Leeds, Division of Rheumatic and Musculoskeletal Disease, St James's University Hospital</name>
      <address>
        <city>Leeds</city>
        <zip>LS9 7TF</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Francesco Del Galdo, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal Free Hospital, University College London</name>
      <address>
        <city>London</city>
        <zip>NW3 2QG</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Christopher Denton, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Manchester, Rheumatic Diseases Centre, Clinical Sciences</name>
      <address>
        <city>Manchester,Salford</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Ariane Herrick</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>Croatia</country>
    <country>Egypt</country>
    <country>France</country>
    <country>Germany</country>
    <country>Hungary</country>
    <country>Italy</country>
    <country>Romania</country>
    <country>Russian Federation</country>
    <country>Serbia</country>
    <country>Spain</country>
    <country>Switzerland</country>
    <country>Turkey</country>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>December 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 9, 2013</study_first_submitted>
  <study_first_submitted_qc>April 13, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 17, 2013</study_first_posted>
  <last_update_submitted>December 21, 2015</last_update_submitted>
  <last_update_submitted_qc>December 21, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 22, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Pecs</investigator_affiliation>
    <investigator_full_name>Prof. Laszlo Czirjak</investigator_full_name>
    <investigator_title>Prof. Laszlo Czirjak</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Sclerosis</mesh_term>
    <mesh_term>Scleroderma, Systemic</mesh_term>
    <mesh_term>Scleroderma, Diffuse</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

